# US 2022/0032022 A1 · Nasal drug delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0032022 A1
- Document ID: US20220032022A1
- Status: Published application
- Kind: A1
- Application number: 17/476,334
- Filed: 2021-09-15
- Published: 2022-02-03
- Earliest claimed: 2019-03-28
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of The Leland Stanford Junior University
- Inventors: Adam GOLD; Ashley SEEHUSEN; Jonathan TOMA; Shira KOSS
- Web page: https://patentgrep.com/patent/US20220032022A1

## CPC

- A61M 11/006: {operated by applying mechanical pressure to the liquid to be sprayed or atomised}
- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- A61M 11/02: operated by air {or other gas} pressure applied to the liquid {or other product} to be sprayed or atomised {(sprayers for horticulture A01G, A01H; killing insects A01M; air humidifying by nozzles F24F6/14, F24F6/18; cooling by spraying F28B, F28C)}
- A61M 15/0021: {Mouthpieces therefor}
- A61M 15/08: Inhaling devices inserted into the nose
- B05B 1/14: with multiple outlet openings (B05B1/02, B05B1/26 take precedence); with strainers in or outside the outlet opening
- B05B 1/3436: {the interface being a plane perpendicular to the outlet axis}
- A61M 11/007: {Syringe-type or piston-type sprayers or atomisers}
- A61M 11/008: {by squeezing, e.g. using a flexible bottle or a bulb}
- A61M 16/0488: {Mouthpieces; Means for guiding, securing or introducing the tubes (guiding or introducing with laryngoscopes A61B1/267; holding devices on the body A61M25/02)}
- A61M 2202/0468: non-physiological
- A61M 2202/048: Anaesthetics
- A61M 2205/0216: Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
- A61M 2205/583: by visual feedback
- A61M 2206/16: Rotating swirling helical flow, e.g. by tangential inflows
- A61M 2207/00: Methods of manufacture, assembly or production
- A61M 2209/06: Packaging for specific medical equipment
- A61M 2209/10: Equipment for cleaning
- A61M 2210/0618: Nose
- A61M 2210/0681: Sinus (maxillaris)
- B05B 1/26: with means for mechanically breaking-up or deflecting the jet after discharge, e.g. with fixed deflectors; Breaking-up the discharged liquid or other fluent material by impinging jets
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

Devices, systems, and methods for treating chronic rhinosinutisits (CRS) are described herein. The devices can have a guide member defining at least one lumen therethrough. A drug delivery component is advanced through the lumen to deliver a substance to the sino-nasal cavity of a patient. Once the drug delivery component is positioned at the desired area in the sino-nasal cavity, a user actuates the system to deliver the substance to the target area. Actuation of the system delivers the substance to the middle meatus, osteo-meatal complex, or other areas within the sino-nasal cavity of the patient.

## Claims

### Claim 1

A drug delivery system for delivering a substance into a subject, comprising:
a housing for carrying the substance within;
a guide member configured for insertion at least partially into a nasal cavity of the subject, the guide member having at least one lumen defined therethrough;
a flexible member translatable through the at least one lumen of the guide member;
a curved portion defined along the flexible member and having one or more openings defined at a distal end of the curved portion, wherein the curved portion extends at a predetermined curvature relative to the flexible member; and
an alignment guide extending from the housing such that the alignment guide and guide member define an angle configured for positioning the curved portion within a predetermined position within the nasal cavity.

### Claim 2 (depends on 1)

The drug delivery system of claim 1, wherein the flexible member is detachable from the housing.

### Claim 3 (depends on 1)

The drug delivery system of claim 1, wherein the one or more openings are in fluid communication with the substance.

### Claim 4 (depends on 1)

The drug delivery system of claim 1, further comprising an actuator for ejecting the substance through the one or more openings.

### Claim 5 (depends on 1)

The drug delivery system of claim 1, wherein the flexible member forms a loop along the curved portion.

### Claim 6 (depends on 1)

The drug delivery system of claim 1, wherein the guide member and flexible member are rotatable about a longitudinal axis relative to the housing.

### Claim 7 (depends on 6)

The drug delivery system of claim 6, wherein the curved portion is rotatable about the longitudinal axis such that the curved portion is positioned in an opposite direction.

### Claim 8 (depends on 1)

The drug delivery system of claim 1, wherein the predetermined curvature defines a pigtail shape.

### Claim 9 (depends on 1)

The drug delivery system of claim 1, wherein the one or more openings have a nozzle configuration.

### Claim 10 (depends on 1)

The drug delivery system of claim 1, wherein the alignment guide is configured for placement against an upper lip of the subject.

### Claim 11 (depends on 1)

The drug delivery system of claim 1, wherein the angle between the alignment guide and guide member ranges between 110 and 120 degrees.

### Claim 12 (depends on 11)

The drug delivery system of claim 11, wherein the angle between the alignment guide and guide member is about 112.5 degrees.

### Claim 13 (depends on 1)

The drug delivery system of claim 1, wherein the housing is in fluid communication with the one or more openings through the flexible member.

### Claim 14 (depends on 1)

The drug delivery system of claim 1, wherein the substance is a drug selected from the group consisting of cystalloids, corticosteroids, antihistamines, anticholinergics, antibiotics, antifungals, triptans, metabolites, NSAIDs, hormones, central nervous system agents, benzodiazepines, and anesthetics.

### Claim 15

A method of delivering a substance into a subject, comprising:
aligning a guide member relative to a first nostril of the subject via an alignment guide extending from a housing such that the alignment guide is positioned against the subject;
inserting the guide member at least partially into the first nostril of the subject;
advancing a flexible member through the at least one lumen of the guide member while maintaining a position of the guide member relative to the subject via the alignment guide such that a curved portion of the flexible member is advanced along a tissue surface and into a middle meatus of the subject; and
delivering the substance through one or more openings defined at a distal end of the curved portion and into the middle meatus.

### Claim 16 (depends on 15)

The method of claim 15, further comprising withdrawing the flexible member proximally into the guide member and removing the guide member from the first nostril.

### Claim 17 (depends on 16)

The method of claim 16, further comprising rotating the guide member and flexible member about a longitudinal axis of the guide member relative to the alignment guide.

### Claim 18 (depends on 17)

The method of claim 17, further comprising indicating to the subject a direction of the guide member and flexible member relative to the alignment guide.

### Claim 19 (depends on 17)

The method of claim 17, further comprising aligning the guide member relative to a second nostril of the subject via the alignment guide.

### Claim 20 (depends on 19)

The method of claim 19, further comprising advancing the flexible member through the at least one lumen of the guide member such that the curved portion of the flexible member is positioned in a opposite direction.

### Claim 21 (depends on 15)

The method of claim 15, wherein delivering the substance through the one or more openings comprises atomizing the substance into the middle meatus.

### Claim 22 (depends on 15)

The method of claim 15, further comprising delivering the substance through one or more openings defined at a distal end of the guide member.

### Claim 23

A drug delivery system, comprising:
a housing for carrying the substance within;
a guide member configured for insertion at least partially into a nasal cavity of the subject, the guide member having at least one lumen defined therethrough;
a flexible member translatable through the at least one lumen of the guide member;
a distal portion defined along the flexible member and having one or more openings defined at a distal end of the distal portion; and
an alignment guide extending from the housing such that the alignment guide and guide member define an angle configured for positioning a portion of the flexible member within a target location within the nasal cavity.

### Claim 24 (depends on 23)

The drug delivery system of claim 23, wherein the flexible member is detachable from the housing.

### Claim 25 (depends on 23)

The drug delivery system of claim 23, wherein the one or more openings are in fluid communication with the substance.

### Claim 26 (depends on 23)

The drug delivery system of claim 23, further comprising an actuator for ejecting the substance through the one or more openings.

### Claim 27 (depends on 23)

The drug delivery system of claim 23, wherein the flexible member forms a loop along the distal portion.

### Claim 28 (depends on 23)

The drug delivery system of claim 23, wherein the guide member and flexible member are rotatable about a longitudinal axis relative to the housing.

### Claim 29 (depends on 28)

The drug delivery system of claim 28, wherein the distal portion is rotatable about the longitudinal axis such that the distal portion is positioned in an opposite direction.

### Claim 30 (depends on 23)

The drug delivery system of claim 23, wherein the one or more openings have a nozzle configuration.

### Claim 31 (depends on 23)

The drug delivery system of claim 23, wherein the alignment guide is configured for placement against an upper lip of the subject.

### Claim 32 (depends on 23)

The drug delivery system of claim 23, wherein the angle between the alignment guide and guide member ranges between 110 and 120 degrees.

### Claim 33 (depends on 32)

The drug delivery system of claim 32, wherein the angle between the alignment guide and guide member is about 112.5 degrees.

### Claim 34 (depends on 23)

The drug delivery system of claim 23, wherein the housing is in fluid communication with the one or more openings through the flexible member.

### Claim 35 (depends on 34)

The drug delivery system of claim 34, further comprising a reservoir in fluid communication with the one or more openings and containing a drug selected from the group consisting of crystalloids, corticosteroids, antihistamines, anticholinergics, antibiotics, antifungals, triptans, metabolites, NSAIDs, hormones, central nervous system agents, benzodiazepines, and anesthetics.

### Claim 36 (depends on 34)

The drug delivery system of claim 34, wherein the guide member further comprises one or more openings.

### Claim 37

A drug delivery system, comprising:
a housing for carrying a drug within;
a guide member configured for insertion simultaneously at least partially into both nasal cavities of a subject, the guide member having two lumens defined therethrough for extending into a respective nasal cavity;
at least two flexible members translatable simultaneously through a respective lumen of the guide member and into the respective nasal cavity;
a distal portion defined along each of the at least two flexible members and having one or more openings defined at each respective distal end; and
an alignment guide such that the alignment guide and guide member define an angle configured for positioning each flexible member within a predetermined position within each respective nasal cavity.

### Claim 38 (depends on 37)

The drug delivery system of claim 37, wherein at least one of the flexible members is detachable from the housing.

### Claim 39 (depends on 37)

The drug delivery system of claim 37, wherein the one or more openings are in fluid communication with the drug.

### Claim 40 (depends on 37)

The drug delivery system of claim 37, further comprising an actuator for ejecting the drug through the one or more openings.

### Claim 41 (depends on 37)

The drug delivery system of claim 37, wherein each flexible member is configured to have an atraumatic distal end.

### Claim 42 (depends on 37)

The drug delivery system of claim 37, wherein the one or more openings have a nozzle configuration.

### Claim 43 (depends on 37)

The drug delivery system of claim 37, wherein the alignment guide is configured for placement against an upper lip of the subject.

### Claim 44 (depends on 37)

The drug delivery system of claim 37, wherein the angle between the alignment guide and guide member ranges between 110 and 120 degrees.

### Claim 45 (depends on 44)

The drug delivery system of claim 44, wherein the angle between the alignment guide and guide member is about 112.5 degrees.

### Claim 46 (depends on 37)

The drug delivery system of claim 37, wherein the housing is in fluid communication with the one or more openings through each flexible member.

### Claim 47 (depends on 46)

The drug delivery system of claim 46, further comprising a reservoir in fluid communication with the one or more openings and containing a drug selected from the group consisting of crystalloids, corticosteroids, antihistamines, anticholinergics, antibiotics, antifungals, triptans, metabolites, NSAIDs, hormones, central nervous system agents, benzodiazepines, and anesthetics.
